Tag: <span>Mesothelioma News</span>

SELLAS Life Sciences Group Announces Upcoming Presentation Of Phase 2 …

In addition, SELLAS announced today that ZELTHERVA has been formally accepted by the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research as the proprietary name for SELLAS ‘s WT1 vaccine is a late clinical-stage cancer immu…

$55 Million To Be Paid By Johnson & Johnson In Talcum Powder Case

Johnson & Johnson was ordered to pay $55 million in a talcum powder case for feminine hygiene products that caused ovarian cancer.

Canada’s Prime Minister Trudeau Commits to Ban Asbestos

Canadian Prime Minister Justin Trudeau recently announced what labor and public health groups have spent years waiting to hear about the nation’s asbestos epidemic. “We’ve actually made the commitment that we are moving forward on a ban,” Trudeau said. “We know that its impact on workers far outweighs any benefits that it might provide.” Trudeau…

The post Canada’s Prime Minister Trudeau Commits to Ban Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Canada’s Prime Minister Trudeau Commits to Ban Asbestos

Canadian Prime Minister Justin Trudeau recently announced what labor and public health groups have spent years waiting to hear about the nation’s asbestos epidemic. “We’ve actually made the commitment that we are moving forward on a ban,” Trudeau said. “We know that its impact on workers far outweighs any benefits that it might provide.” Trudeau…

The post Canada’s Prime Minister Trudeau Commits to Ban Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Bayer to Showcase Latest Oncology Research at ASCO 2016

Bayer announced today that data from several studies across its oncology portfolio will be presented at the 52 Annual Meeting of the American Society of Clinical Oncology , taking place June 3-7 in Chicago. The data represent clinical research on Bayer’s oncology products, as well as continued investigation of Xofigo injection in other areas of metastatic castration-resistant prostate cancer .

Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting

The avelumab presentations, from the rapidly accelerating JAVELIN clinical development program, include new study results from a number of difficult-to-treat cancers, including data from the pivotal Phase II trial of avelumab being investigated as seco…

New Research Reviews Tests For Improved Mesothelioma Diagnosis, According To Surviving Mesothelioma

A new study conducted in Canada suggests that performing tests for p16 deletion and BAP1 loss may be good ways to rule out malignant mesothelioma in people suspected of having the asbestos cancer. Surviving Mesothelioma has just posted an article expla…

Appeal for information after family man dies from asbestos-related cancer

Home News Sport Announcements Jobs Most popular UK news Send us your news Cars Traffic & travel Business Directory Property Dating Desktop site A RETIRED lift engineer’s son is working with solicitors to help discover how his father was exposed to …